Patent Assignment
Reel/Frame 049600/0536
Assignment of Assignor's Interest
Recorded: 2019-06-26
Pages: 12
Assignors
PAPAIOANNOU, NIKOLAOS
Executed: 2019-04-22
MILLER, THOMAS ALLEN
Executed: 2019-04-18
SHIPPS, GERALD WAYNE, JR.
Executed: 2019-05-22
TRAVINS, JEREMY MARK
Executed: 2019-04-26
EHMANN, DAVID EDWARD
Executed: 2019-04-22
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Patent:
10,730,874 →
Application:
16/299,996 →
Publication:
US 2019/0284182
PCT:
PCT/US2019/021897 ↗
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 26, 2019
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0564 →
Assignment of Assignor's Interest
Jun 26, 2019
From: RAE, ALASTAIR; ELLARD, JOHN MARK
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 049600/0497 →
Assignment of Assignor's Interest
Jun 26, 2019
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 049600/0552 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 049600/0583 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0587 →
Assignment of Assignor's Interest
Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
Assignment of Assignor's Interest
Mar 14, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 059250/0619 →